[ Back ]   [ More News ]   [ Home ]
Mazor Robotics Announces Humble Surgical Hospital Acquires Renaissance System

CAESAREA, Israel — (BUSINESS WIRE) — October 2, 2012 — Mazor Robotics Ltd. (TASE: MZOR), a developer of innovative surgical robots and complementary products, today announced that Humble Surgical Hospital in Humble, Texas acquired its Renaissance™ system.

Humble Surgical Hospital is a multispecialty surgical hospital located in the heart of the city of Humble, Texas. HSH is a physician owned hospital and was established in 2009 to provide premium, efficient, and affordable health care services to a growing community in north Houston.

“As an early adopter of the Renaissance technology, Humble Surgical Hospital represents the best-of-its kind medical facility with the utmost dedication to its patient base,” said Ori Hadomi, Chief Executive Officer of Mazor. “This system sale further confirms the significant value that Renaissance adds to surgical practices, and it marks an outstanding achievement for our product.”

Renaissance, Mazor Robotics’ next generation surgical guidance system for spine procedures, is transforming spine surgery from freehand operations to highly-accurate, state-of-the-art procedures, with less radiation – even for minimally invasive surgery, scoliosis, and other complex spinal deformity cases. It is the only robotic technology for spine surgery available in the marketplace.

About Mazor

Mazor Robotics (TASE: MZOR) is dedicated to the development and marketing of innovative surgical robots and complementary products that provide a safer surgical environment for patients, surgeons, and operating room staff. Mazor Robotics’ flagship product, Renaissance™, is a state-of-the-art surgical robotic system that enables surgeons to conduct spine surgeries in an accurate and secure manner. Mazor Robotics systems have been successfully used in the placement of over 20,000 implants in the United States and Europe. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of Mazor Robotics technology. For more information, please visit www.mazorrobotics.com.



Contact:

U.S. Contacts:
EVC Group
Aimee Gordon, 646-445-4800 (Investors)
Email Contact
Robert Jones, 646-445-4800 (Investors)
Email Contact
Chris Gale, 646-201-5431 (Media)
Email Contact